Duane S Pinto

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Cardiac manifestations of Lyme disease
    Duane S Pinto
    Harvard Medical School, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Med Clin North Am 86:285-96. 2002
  2. ncbi request reprint Reperfusion strategies for ST-elevation myocardial infarction
    Saumil R Shah
    Division of Cardiology, Beth Israel Deaconess Medical Center, 350 Longwood Avenue, First Floor, Boston, MA 02115, USA
    Curr Cardiol Rep 9:281-8. 2007
  3. doi request reprint Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database
    Duane S Pinto
    Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Circ Cardiovasc Qual Outcomes 5:52-61. 2012
  4. doi request reprint Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes
    Duane S Pinto
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 52:1758-68. 2008
  5. ncbi request reprint Clinical problem-solving. A sailor's heartbreak
    Duane S Pinto
    Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 353:934-9. 2005
  6. ncbi request reprint Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial
    Duane S Pinto
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 48:32-6. 2006
  7. doi request reprint A 43-year-old man with angina, elevated troponin, and lateral ST depression: management of acute coronary syndromes
    Duane S Pinto
    Harvard Medical School, and Cardiac Catheterization Laboratory, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    JAMA 303:54-63. 2010
  8. doi request reprint Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction
    C Michael Gibson
    TIMI Study Group, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 51:546-51. 2008
  9. ncbi request reprint Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina
    Albert J Deibele
    Division of Cardiology, Duluth Clinic, Duluth, Minnesota, USA
    J Thromb Thrombolysis 22:47-50. 2006
  10. ncbi request reprint Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter
    Thomas H Hauser
    Cardiovascular Division, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 93:1173-6. 2004

Detail Information

Publications46

  1. ncbi request reprint Cardiac manifestations of Lyme disease
    Duane S Pinto
    Harvard Medical School, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Med Clin North Am 86:285-96. 2002
    ..Routine therapy and screening of patients with idiopathic dilated cardiomyopathy is of limited utility and should be reserved for patients with clear history of antecedent Lyme disease or tick bite...
  2. ncbi request reprint Reperfusion strategies for ST-elevation myocardial infarction
    Saumil R Shah
    Division of Cardiology, Beth Israel Deaconess Medical Center, 350 Longwood Avenue, First Floor, Boston, MA 02115, USA
    Curr Cardiol Rep 9:281-8. 2007
    ..The evidence supporting facilitated PCI varies according to the pharmacologic regimen at this time...
  3. doi request reprint Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database
    Duane S Pinto
    Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Circ Cardiovasc Qual Outcomes 5:52-61. 2012
    ....
  4. doi request reprint Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes
    Duane S Pinto
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 52:1758-68. 2008
    ..The aim of this study was to determine the economic impact of several anticoagulation strategies for moderate- and high-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients managed invasively...
  5. ncbi request reprint Clinical problem-solving. A sailor's heartbreak
    Duane S Pinto
    Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 353:934-9. 2005
  6. ncbi request reprint Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial
    Duane S Pinto
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 48:32-6. 2006
    ....
  7. doi request reprint A 43-year-old man with angina, elevated troponin, and lateral ST depression: management of acute coronary syndromes
    Duane S Pinto
    Harvard Medical School, and Cardiac Catheterization Laboratory, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    JAMA 303:54-63. 2010
    ..The timing of cardiac catheterization, for whom catheterization is indicated, and the rationale for medication treatment are discussed...
  8. doi request reprint Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction
    C Michael Gibson
    TIMI Study Group, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 51:546-51. 2008
    ..The goal of this analysis was to evaluate the association of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grade (TMPG) with sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)...
  9. ncbi request reprint Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina
    Albert J Deibele
    Division of Cardiology, Duluth Clinic, Duluth, Minnesota, USA
    J Thromb Thrombolysis 22:47-50. 2006
    ....
  10. ncbi request reprint Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter
    Thomas H Hauser
    Cardiovascular Division, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 93:1173-6. 2004
    ..Recurrent arrhythmia was not more common with amiodarone...
  11. ncbi request reprint Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease
    Gaurav M Patel
    Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Nucl Cardiol 11:408-13. 2004
    ..Although the mechanism of lung uptake is thought to be similar for the two isotopes, their physiologic characteristics are different. No direct comparison of lung uptake for the two isotopes has been reported...
  12. doi request reprint Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase
    Duane S Pinto
    Division of Cardiology, Interventional Section, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Boston MA 02115, USA
    Circulation 124:2512-21. 2011
    ..We hypothesized that delays resulting from transfer would reduce the survival advantage of X-PCI compared with O-FT...
  13. doi request reprint Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study)
    Duane S Pinto
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 101:303-7. 2008
    ..IRA patency after fibrinolytic administration is related to admission glucose independent of clopidogrel administration...
  14. ncbi request reprint Administration of intracoronary eptifibatide during ST-elevation myocardial infarction
    Duane S Pinto
    Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, Massachusetts, USA
    Am J Cardiol 96:1494-7. 2005
    ..Further prospective randomized trials are warranted to evaluate the efficacy and safety of intracoronary eptifibatide...
  15. ncbi request reprint Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
    Ajay J Kirtane
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    J Am Coll Cardiol 45:1781-6. 2005
    ..We hypothesized that elevated blood urea nitrogen (BUN) would be associated with adverse outcomes independent of serum creatinine (sCr)-based estimates of kidney function in patients with acute coronary syndromes (ACS)...
  16. ncbi request reprint Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients
    Ramon Kumar
    Department of Medicine, Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am J Cardiol 100:1187-91. 2007
    ....
  17. pmc Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis
    Matthew R Reynolds
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am Heart J 154:1221-7. 2007
    ..Sirolimus-eluting stents (SESs) were recently shown to be superior to vascular brachytherapy for the treatment of restenosis within a bare metal stent. No economic comparison of these alternative strategies has yet been reported...
  18. ncbi request reprint Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality
    C Michael Gibson
    TIMI Study Chairman s Office, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Am Coll Cardiol 42:1535-43. 2003
    ..We hypothesized that impaired renal function would also be associated with poorer clinical outcomes among patients with ST-segment elevation myocardial infarction (STEMI) treated with fibrinolysis...
  19. ncbi request reprint Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia
    Duane S Pinto
    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA
    Catheter Cardiovasc Interv 58:65-8. 2003
    ..In selected patients with HIT, the combination of a direct thrombin inhibitor, lepirudin, and abciximab, tirofiban, or eptifibatide appears to be a safe and effective anticoagulation strategy for PCI...
  20. ncbi request reprint Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction
    Ajay J Kirtane
    Department of Medicine, Beth Israel Deaconess Medical Center, USA
    J Thromb Thrombolysis 17:177-84. 2004
    ..8, p = 0.02) and 30-day congestive heart failure (OR 4.4, p = 0.02). In STEMI, angiographic indices of incomplete reperfusion are associated with an elevated LVEDP, and elevated LVEDP is associated with adverse clinical outcomes...
  21. ncbi request reprint Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
    Duane S Pinto
    TIMI Study Group and the Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Boston, MA 02115, USA
    Circulation 114:2019-25. 2006
    ..We also hypothesized that in addition to PPCI delays, patient risk factors would significantly modulate the relative survival advantage of PPCI over fibrinolysis...
  22. doi request reprint Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy
    Anjan K Chakrabarti
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Cardiol 27:651-4. 2012
    ..This benefit diminishes as PCI-related delay increases. This review examines recent data exploring this relationship, offering insight into possible mechanisms for the time-dependent benefit of PCI...
  23. ncbi request reprint Optimizing reperfusion in patients with STEMI: a critical evaluation of pharmacologic and non-pharmacologic strategies
    Xiaoyu Yang
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Interventional Cardiology Section, 1 Deaconess Road, Palmer 415, Boston, MA, 02215, USA
    Am J Cardiovasc Drugs 13:399-406. 2013
    ..This manuscript reviews the current state of the art in STEMI care, describing both pharmacologic and non-pharmacologic strategies for reperfusion. ..
  24. ncbi request reprint Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels
    Gui Fu Wu
    Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA
    J Invasive Cardiol 20:76-80. 2008
    ..Ischemic heart disease remains the major underlying cause for congestive heart failure, however, the effects of intravenous and intracoronary nesiritide on coronary circulation have not been adequately studied...
  25. doi request reprint Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review
    Kashish Goel
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Am Heart J 165:451-67. 2013
    ..We conducted a systematic review to examine the association between time to reperfusion and incident HF and/or left ventricular dysfunction...
  26. doi request reprint Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia
    Robina Matyal
    Beth Israel Deaconess Medical Center, Department of Anesthesia and Critical Care, Boston, MA, USA
    J Mol Cell Cardiol 53:891-8. 2012
    ..Local infiltration of NPY significantly improved collateral vessel formation, blood flow and myocardial function. We believe activation of NPY receptors may be a potential target therapy for patients with diffuse coronary artery disease...
  27. ncbi request reprint Drug eluting stents for ST-elevation myocardial infarction: risk and benefit
    Jason Ryan
    Beth Israel Deaconess Medical Center and Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA
    J Thromb Thrombolysis 24:293-9. 2007
    ..This review with discuss the theoretical risks and benefits of DES for STEMI, the available data regarding their use, and the areas where future studies are needed...
  28. ncbi request reprint Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis
    Robert T Sperling
    Section of Interventional Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Catheter Cardiovasc Interv 59:459-62. 2003
    ..Acute renal hemodialysis may reverse the inhibitory effect of eptifibatide on platelet aggregation in these patients...
  29. ncbi request reprint Stent thrombosis after successful sirolimus-eluting stent implantation
    Allen Jeremias
    Section of Interventional Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass, USA
    Circulation 109:1930-2. 2004
    ..5% to 1.9% of patients with bare metal stents. The incidence of ST with drug-eluting stents is less well studied, particularly among patients outside of clinical trials...
  30. doi request reprint Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A)
    Matthew R Reynolds
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    J Am Coll Cardiol 60:2683-92. 2012
    ..The aim of this study was to evaluate the cost-effectiveness of transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for patients with severe aortic stenosis and high surgical risk...
  31. ncbi request reprint Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy)
    Duane S Pinto
    Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    Am J Cardiol 91:976-8, A4. 2003
  32. ncbi request reprint Zebra or horse?
    Daniel Tsyvine
    Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    Am J Med 120:591-3. 2007
  33. ncbi request reprint Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
    Jason Ryan
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Coron Artery Dis 17:667-71. 2006
    ..In this chapter, we discuss the theoretical risks and benefits of drug-eluting stents for ST elevation acute myocardial infarction, the available data regarding their use, and the areas in which future studies are needed...
  34. ncbi request reprint Door-to-balloon delays with percutaneous coronary intervention in ST-elevation myocardial infarction
    Duane S Pinto
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Am Heart J 151:S24-9. 2006
    ..Continued efforts, aimed at reducing the time to therapy with PCI and fibrinolysis, are of paramount importance...
  35. ncbi request reprint Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter
    Thomas H Hauser
    Cardiovascular Division, Department of Medicine, Baker 4, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Cardiol 91:1437-41. 2003
    ..Most adverse events occurred beyond the usual time period for in-hospital monitoring of the initiation of AAMs...
  36. ncbi request reprint Inhaled nitric oxide as an adjunct to suction thrombectomy for pulmonary embolism
    Salomao Faintuch
    Departments of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue WCC 308, Boston, Massachusetts 02215, USA
    J Vasc Interv Radiol 15:1311-5. 2004
    ..The treatment with this inhalable vasodilator was based on the hypothesis that prolonged ischemia had induced microcirculatory vasospasm, persistent after removal of the central clot...
  37. ncbi request reprint Images in clinical medicine. Prinzmetal's angina
    H S Vincent Chen
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    N Engl J Med 349:e1. 2003
  38. doi request reprint Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents
    David A Burke
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Curr Cardiol Rep 14:493-501. 2012
    ....
  39. ncbi request reprint Current clinical characteristics and economic impact of subacute stent thrombosis
    Matthew R Reynolds
    Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Invasive Cardiol 14:364-8. 2002
    ..Conclusions. Despite its low overall frequency, the clinical and economic costs of SAT are substantial. Specific strategies at preventing its occurrence are warranted, particularly in high-risk situations...
  40. pmc Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rate
    Duane S Pinto
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    BMC Cardiovasc Disord 3:7. 2003
    ..The emergency department diagnosis of sinus versus nonsinus tachycardia is an important clinical challenge. The objective of this study was to identify subjects with a high prevalence of nonsinus tachycardia...
  41. ncbi request reprint Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities
    Gregory P Sanders
    Cardiovascular Division, Department of Medicine, and Boston University School of Medicine, Boston, Mass 02215, USA
    J Nucl Cardiol 10:140-7. 2003
    ..We sought to investigate the association between increased resting Tl-201 lung-to-heart ratio (LHR) and hemodynamic indices of LV dysfunction, indices of myocardial perfusion, and extent of CAD...
  42. ncbi request reprint Images in clinical medicine. Ventricular septal rupture after myocardial infarction
    Duane S Pinto
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    N Engl J Med 347:1334. 2002
  43. ncbi request reprint A novel approach using atherectomy for chronic total occlusion of the brachial artery: a case report
    Yuri B Pride
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Vasc Med 12:207-10. 2007
    ..We describe a case of chronic brachial artery ischemia due to atherosclerotic disease treated with the SilverHawk plaque excision system and review the available data regarding its use...
  44. doi request reprint Lyme carditis
    Airley E Fish
    Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Infect Dis Clin North Am 22:275-88, vi. 2008
    ..Cardiovascular manifestations of Lyme disease were first reported nearly 30 years ago. This article describes Lyme carditis, its epidemiology, pathophysiology, methods of diagnosis, and treatment options...
  45. doi request reprint Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'
    Allen Jeremias
    Division of Cardiovascular Medicine, Stony Brook University Medical Center, Stony Brook, NY 11794, USA
    Coron Artery Dis 19:111-5. 2008
    ..This study examined the performance of SES in a 'real world' setting by comparing the outcomes of trial-eligible versus ineligible patients undergoing percutaneous coronary intervention...
  46. ncbi request reprint U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction
    Duane S Pinto
    J Am Coll Cardiol 46:178-80. 2005